The future of the global HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets. The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the HLA typing for transplant
market by product type (reagents and consumables, instruments, and software and
services), technology (molecular assay technologies and non- molecular assay
technologies), application (diagnostic, research, and others), end use industry
(independent reference laboratories, hospitals and transplant centres, research
laboratories and academic institutes, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will
grow at a faster pace and why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the
emerging trends in this market and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
molecular and non- molecular are the major segments of HLA typing for
transplant market by technology. Lucintel forecasts that molecular will remain
the larger segment due to its high throughput for the quick processing of
samples, ability to detect wide variety of HLA alleles, and excellent accuracy.
Within this market,
independent reference laboratory will remain the largest segment over the
forecast period.
North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.
Thermo Fisher
Scientific, Bio-Rad Laboratories, Qiagen, Omixon, GenDx, Illumina, TBG
Diagnostics, Dickinson, Takara Bio, and F. Hoffman-La Roche are the major
suppliers in the HLA typing for transplant market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment